Beam Therapeutics Inc. (BEAM)
Drugs • Health Care
Percentage
Change
| Mar 21 | Feb 22 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|
Net Income to Common | -377 | -80 | ||||
Net Income | -377 | -80 | ||||
Profit | -377 | -80 | ||||
Net Income Continuing | -377 | -80 | ||||
Income Tax Expense | -0 | 0 | ||||
Pretax Income | -377 | -80 | ||||
Total Non-operating Income | 39 | 304 | ||||
Operating Income | -416 | -384 | ||||
Total Revenue | 64 | 140 | ||||
Total Costs and Expenses | -479 | -523 | ||||
Operating Expenses | -479 | -523 | ||||
Research and Development Expenses | -368 | -410 | ||||
Selling, General & Administrative Expenses | -112 | -114 |